Inhibition of GTPase KRAS G12D : a review of patent literature

INTRODUCTION: is highly prevalent and represents a promising therapeutic target, yet there are currently no approved inhibitors for it. AREA COVERED: in terms of design strategies, chemical structures, biological activities, and clinical advancements. EXPERT OPINION: also holds significant potential.